insights_auto
Why is ORX down ၂.၄၇%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
၁၃.၄၀ SEK
arrow_downward
-၂.၄၇%(-၀.၃၄) 1D
အောက် ၂, GMT+၂ ၁၁:၄၉:၀၉ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
၁၄.၂၈ SEK
High
၁၄.၂၈ SEK
Low
၁၃.၃၀ SEK
Mkt. cap
၄၇.၀၇ ကုဋေ
Avg. vol.
၄.၂၉ သောင်း
Volume
၁.၀၈ သောင်း
P/E ratio
၀.၅၇
52-wk high
၄၃.၄၀ SEK
52-wk low
၁၂.၂၀ SEK
EPS
၂၃.၆၁ SEK
Shares outstanding
၃.၅၁ ကုဋေ
No. of employees
၆၁
Open
၁၄.၂၈ SEK
High
၁၄.၂၈ SEK
Low
၁၃.၃၀ SEK
Mkt. cap
၄၇.၀၇ ကုဋေ
Avg. vol.
၄.၂၉ သောင်း
Volume
၁.၀၈ သောင်း
P/E ratio
၀.၅၇
52-wk high
၄၃.၄၀ SEK
52-wk low
၁၂.၂၀ SEK
EPS
၂၃.၆၁ SEK
Shares outstanding
၃.၅၁ ကုဋေ
No. of employees
၆၁
News stories
From web sources and news partners
GlobeNewswire
·
ပြီးခဲ့သည့် ၉ မိနစ်
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
24/7 Wall St.
·
ပြီးခဲ့သည့် ၅ မိနစ်
Peter Brandt Calls XRP a "Fool Coin" Just Before 473 Million XRP Lists on Nasdaq. Does Payment Utility Count for Anything in the Price?
Seeking Alpha
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
SPYM ETF: S&P 500 Monthly Dashboard For October
Investor's Business Daily
·
ပြီးခဲ့သည့် ၁ နာရီ
Twilio To Join S&P 500 Index
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB